By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Actinium Pharmaceuticals, Inc. 

501 Fifth Avenue

New York City  New York  10017  U.S.A.
Phone: 646-459-4201 Fax: n/a


SEARCH JOBS








Company News
Actinium (ATNM.OB) Announces Closing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 8/3/2017 11:58:19 AM
Actinium (ATNM.OB) Announces Proposed Public Offering Of Common Stock And Warrants To Purchase Stock 7/28/2017 10:48:20 AM
Actinium (ATNM.OB) Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 7/28/2017 8:18:27 AM
Actinium (ATNM.OB) To Host Webinar Focused On Actimab-A And Recent Developments Related To CD33 Targeted AML Therapies On July 13, 2017 At 8:00 Am ET 7/13/2017 10:24:17 AM
Actinium (ATNM.OB) To Host Webinar Focused On Actimab-A And Recent Developments Related To CD33 Targeted AML Therapies On July 13, 2017 At 8:00 Am ET 7/6/2017 11:04:39 AM
Actinium (ATNM.OB) Announces Appointment Of Nitya Ray, Ph.D. As Executive Vice-President, Head Of Product Development, Manufacturing And Supply Chain And Other Key Hires In Its Product Development And Manufacturing Teams 6/15/2017 11:12:16 AM
Actinium (ATNM.OB) Issues Mid-Year Letter To Shareholders Highlighting Accomplishments And Significant Value Enumerating Catalysts Over The Coming Quarters 6/15/2017 7:37:18 AM
Actinium (ATNM.OB) To Host Webinar On June 12th To Update On Pivotal Phase III SIERRA Clinical Trial For Iomab-B 6/12/2017 12:06:15 PM
Actinium (ATNM.OB) Names A New CEO, Effective Immediately 6/9/2017 10:01:27 AM
Actinium (ATNM.OB) Highlights Presence At Upcoming Society Of Nuclear Medicine And Molecular Imaging Annual Meeting 6/8/2017 11:13:46 AM
12345678910...
//-->